Zhitong Finance App learned that Yinnuo Pharmaceutical-B (02591) made the latest shareholders' rights disclosure on August 20, 2026.

Stock name	Name of organization	nature	Pre-change shareholding	Shareholding after the change	Shareholding ratio
Yinnuo Pharmaceutical-B (02591)	Huang Li	Yoshigura	406.21,000 shares	386.11,000 shares	9.19% (latest) 9.67% (previous)
Yinnuo Pharmaceutical-B (02591)	Zheng Weihe	Yoshigura	406.21,000 shares	386.11,000 shares	9.19% (latest) 9.67% (previous)
Yinnuo Pharmaceutical-B (02591)	Cowin China Growth Fund II, L.P.	Yoshigura	26.5564 million shares	2501.64 million shares	5.95% (Latest) 6.32% (Previous)
Yinnuo Pharmaceutical-B (02591)	Cowin Capital Investment Limited	Yoshigura	26.5564 million shares	2501.64 million shares	5.95% (Latest) 6.32% (Previous)
Yinnuo Pharmaceutical-B (02591)	Cowin Capital Investment III Limited	Yoshigura	26.5564 million shares	2501.64 million shares	5.95% (Latest) 6.32% (Previous)
Yinnuo Pharmaceutical-B (02591)	Cowin Capital Investment II Ltd	Yoshigura	26.5564 million shares	2501.64 million shares	5.95% (Latest) 6.32% (Previous)

Note: Changes in the number of shares held may be caused by stock offerings, joint stock splits, etc. Please be careful to compare the actual situation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.